GWIN — Reska Biotech Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMicro Cap

Annual cashflow statement for Reska Biotech, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2013 March 31st	2014 March 31st	R2015 March 31st	2016 March 31st	2017 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-0.044	-0.059	1.07	-2.91	-2.07
Depreciation
Non-Cash Items	0.014	0.032	1.6	5.36	2
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.002	0.032	-0.344	0.377	0.066
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Net Change in Other Assets & Liabilities
Cash from Operating Activities	-0.027	0.004	2.32	2.83	0
Capital Expenditures	0	0	—	-0.032	—
Purchase of Fixed Assets
Other Investing Cash Flow Items	—	—	-2.45	-2.97	0
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities	0	0	-2.45	-3	0
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.026	-0.004	0.34	-0.032	0
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-0.001	0	0.214	-0.214	0